Schizophrenia Clinical Trial
— InSHAPEOfficial title:
Health Promotion and Fitness for Younger and Older Adults With SMI
The goal of this project, which has not changed, is to improve the health and fitness of
persons with serious mental illness (SMI) using an innovative model: In SHAPE Lifestyles.
Participants are randomly assigned to the In SHAPE program or Health Club Membership and
Education only.
The three specific aims of this study are to:
1. To compare the treatment groups with respect to improvement in physical fitness
outcomes, including: (a) health behaviors (engagement in exercise and diet changes);
and (b) indicators of physical fitness.
2. To compare the treatment groups with respect to improvements in mental health outcomes,
including negative symptoms, depression, and self-efficacy.
3. To explore differences in the treatment groups with respect to psychosocial
functioning, health status, and acute service use, and the effects of selected
demographic, clinical, and health behavior variables on primary outcomes.
Status | Completed |
Enrollment | 210 |
Est. completion date | May 2013 |
Est. primary completion date | May 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - age 21 or older - serious mental illness defined by an axis I diagnosis of major depression, bipolar disorder, schizoaffective disorder, or schizophrenia - persistent impairment in multiple areas of functioning (e.g., work, school, self-care) - body mass index (BMI) greater than 25 - able and willing to provide informed consent - on stable pharmacological treatment (same psychiatric medications over prior 2 months) Exclusion Criteria: - residing in nursing home or other institution - diagnosis of dementia or significant cognitive impairment (MMSE<24) - unable to walk one city block - pregnant or planning to become pregnant within the next 18 months - unable to speak English - terminal illness with life expectancy<1 year - current diagnosis of an active substance dependence disorder |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Baycove Human Services | Boston | Massachusetts |
United States | Massachusetts Mental Health Center | Boston | Massachusetts |
United States | Vinfen | Cambridge | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Dartmouth-Hitchcock Medical Center | National Institute of Mental Health (NIMH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Weight | Change in weight over time was measured at baseline, 3-, 6-, 9-, 12-, and 18-months. Measures were weight (kg) and body mass index (kg/m2). | Baseline, 3-, 6-, 9-, 12-, and 18-months | No |
Secondary | Change in Dietary Behaviors | Change in dietary behaviors was assessed over time using a scale adapted from the Stages of Change Modified Motivational Interviewing instrument focused on dietary behaviors and physical activity. | Baseline, 6-, 12-, and 18-months | No |
Secondary | Change in Dietary Intake | Change in dietary intake over time was assessed using the Brief Block Food Frequency Questionnaire and nutrient analysis was conducted with NutritionQuest using a nutrient database developed from the USDA Nutrient Database for Standard Reference. | Baseline, 6-, 12-, and 18-months | No |
Secondary | Change in Serum lipids | Change in serum lipids over time was measured using the CardioChek PA Analyzer, a hand-held dual testing system that produces values for total cholesterol, LDL, HDL, and triglycerides using a multi-panel test strip and a single drop of blood acquired with a finger prick. | Baseline, 6-, 12-, and 18-months | No |
Secondary | Change in Blood Pressure | Change in systolic and diastolic blood pressure over time was measured using a blood pressure cuff. | Baseline, 6-, 12-, and 18-months | No |
Secondary | Change in Cardiorespiratory Fitness | Change in cardiorespiratory fitness over time was measured using the 6 Minute Walk Test (distance in m that a participant can walk in 6 minutes). | Baseline, 6-, 12-, and 18-months | No |
Secondary | Change in Physical Activity | Change in self-reported physical activity was measured over time using the short-form International Physical Activity Questionnaire (IPAQ). | Baseline, 3-, 6-, 9-, 12-, and 18-months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |